Technology | November 01, 2010

3T MRI, Noncontrast Imaging to be Highlighted at RSNA

The Titan 3T is a works-in-progress magnetic resonance (MR) system from Toshiba. The system has several patient-friendly features that are designed to improve the exam experience.

For example, the Pianissimo sound-reduction technology reduces exam noise by up to 90 percent. Additionally, the Titan 3T has a 71-centimeter aperture, which is the largest available and reduces claustrophobia. The system also has the ability to perform contrast-free MRA exams using the company’s fourth-generation non-contrast sequences. Toshiba’s Atlas coil technology eliminates the need to continually reposition patients during multiple exams.

The contrast-free MRA techniques include fresh blood imaging (FBI), contrast-free improved angiography (CIA), time-spatial labeling inversion pulse (Time-SLIP) and time and space angiography (TSA). Contrast-free techniques are important because gadolinium-based contrast agents, often used for MRA, have been directly linked to nephrogenic systemic fibrosis (NSF).

Toshiba’s non-contrast techniques also require less setup time and greatly expand the window for image acquisition.

For more information: www.medical.toshiba.com


Related Content

News | Contrast Media

August 17, 2023 — University of Missouri School of Medicine neurologist Adnan Qureshi, MD recently led a study that ...

Home August 17, 2023
Home
News | Contrast Media

July 3, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR) ...

Home July 03, 2023
Home
News | Contrast Media

May 11, 2021 — The American Institute of Ultrasound in Medicine (AIUM) and the American Society of Echocardiography (ASE ...

Home May 11, 2021
Home
Technology | Contrast Media

July 15, 2019 — The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic ...

Home July 15, 2019
Home
Videos | Contrast Media

Sharon Mulvagh, M.D., FASE, FACC, FRCPC, professor of medicine, division of cardiology, Dalhousie University, Halifax ...

Home June 28, 2019
Home
Feature | Contrast Media | Dave Fornell, Editor

Iodine-based contrast agents used in computed tomography (CT) and catheter-based angiography have been implicated as a ...

Home May 31, 2019
Home
News | Contrast Media

May 9, 2019 — Osprey Medical announced the launch of DyeMINISH, a global patient registry to evaluate the ongoing safety ...

Home May 09, 2019
Home
News | Contrast Media

November 30, 2018 — VigiLanz and Cincinnati Children’s Hospital Medical Center recently announced a collaboration that ...

Home November 30, 2018
Home
News | Contrast Media

In February 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Maryland, to explore ...

Home September 12, 2018
Home
News | Contrast Media

January 19, 2018 — Ligand Pharmaceuticals Inc. announced initiation of a program to develop contrast agents with reduced ...

Home January 19, 2018
Home
Subscribe Now